monocyte
Enable an AI agent to recognise a monocyte, assess its observed state and determine which observations, comparisons or experimental manipulations are justified by the available evidence.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
Researched by: Codex + Grok
Purpose and description
Enable an AI agent to recognise a monocyte, assess its observed state and determine which observations, comparisons or experimental manipulations are justified by the available evidence.
A circulating mononuclear leukocyte of bone-marrow origin that patrols blood and tissues as a phagocyte and antigen-presenting precursor of macrophages and some dendritic cells.
It can be Classify the cell provisionally or confidently using morphology, phenotype and exclusion evidence.; Assign a human blood monocyte subset when the species, compartment and assay support that classification.; Select an additional observation that resolves a specific identity or state ambiguity.; Compare monocyte phenotypes or responses across samples with compatible processing and measurement conditions.; Evaluate whether isolation, sorting, stimulation or culture is compatible with the intended readout and cell viability.; Track a possible differentiation transition and transfer identity to a neighbouring model when sufficient evidence supports it..
Distinguishing features
On a blood smear, assess whether nuclear shape, chromatin and relatively abundant cytoplasm support monocyte identity rather than a segmented granulocyte or typical small lymphocyte; morphology alone may leave ambiguous cells unresolved.
Use a species-appropriate multiparameter phenotype with positive monocyte evidence and exclusion of competing lineages; neither CD14 nor CD16 alone establishes identity.
For human blood cells, assess CD14 and CD16 patterns only after identifying the monocyte population, because these markers also occur outside that population.
When distinguishing a monocyte from a macrophage or dendritic cell, combine compartment, developmental or culture history and phenotype rather than assigning identity from phagocytosis or adherence alone.
Check whether an apparent unusual monocyte is a singlet, an aggregate or a monocyte attached to another cell before interpreting its combined marker profile.
Scope
+ Evidence identifying a cell as a monocyte and excluding plausible alternatives
+ Species, anatomical compartment and collection context
+ Monocyte subset assignment and uncertainty
+ Viability, activation and measured functional capabilities
+ Effects of isolation, storage and experimental manipulation on interpretation
- Patient diagnosis or treatment decisions based on monocyte measurements
- Whole-blood composition and the complete differential blood count
- Bone-marrow progenitor development and haematopoiesis as a system
- Established macrophage and dendritic-cell identities after differentiation
- Whole-tissue inflammation, infection or immune-response dynamics
- Laboratory instruments and assay protocols as independently managed things
Characteristics
- Identity confidence
- supported | provisional | unresolved | excluded, with supporting observations Prevents uncertain cell classification from becoming an assumed biological fact.
- Species
- Taxonomic identifier Marker interpretation and subset terminology require species-specific evidence.
- Source compartment
- Linked blood, marrow, tissue or culture specimen Compartment changes the relevant identity boundaries and interpretation of phenotype.
- Morphological profile
- Observed nuclear shape, chromatin, cytoplasm and granularity, with imaging method Provides independent identity evidence and can flag atypical cells.
- Human blood monocyte subset
- classical | intermediate | nonclassical | unresolved | not applicable; retain CD14/CD16 measurements and gating definition Supports qualified comparisons without treating subset labels as universally applicable or immutable.
- Surface-marker abundance
- Assay-specific fluorescence intensity or calibrated abundance, with marker, controls and normalization Allows identity and state assignments to be checked against the underlying observations.
- Viability
- viable | compromised | dead | unresolved, with assay and observation time Constrains which functional measurements and manipulations remain interpretable.
- Stimulus-response profile
- Named response and assay-specific unit, with stimulus, dose, duration and comparator Describes demonstrated responsiveness without assigning an unsupported global activation label.
- Particle uptake
- Internalized particles per cell or assay-specific uptake signal, with extracellular binding controls Separates measured internalization from surface attachment and from microbial killing.
- Processing exposure
- Linked collection, isolation, storage, thawing and culture events with elapsed times Helps distinguish biological state from changes introduced during preparation.
Also called
Where this came from
wikidata · CC0 1.0
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 5 bundles · 9 layers · 9 findings · 17 questions.
Monocyte identity Evidence that the observed cell is a monocyte rather than a neighbouring or artefactual cell class.
Every subsequent subset, state and action judgement depends on a defensible monocyte identification.
Morphological evidence
Observed cellular features that support or challenge monocyte identity.
Morphology and alternatives
Record nuclear and cytoplasmic observations alongside plausible competing classifications.
- Which observed nuclear, chromatin and cytoplasmic features support monocyte identity under the preparation and imaging method used? measurement
- Could this appearance instead represent an immature myeloid cell, granulocyte, reactive lymphocyte or preparation artefact? boundary
Phenotypic confirmation
Species-appropriate marker evidence and exclusion of misleading events.
Marker-supported identification
Retain the positive and exclusion evidence used to identify a monocyte, including singlet and viability assessment.
- Which measured markers and reference criteria support monocyte identity in this species and specimen type? definition
- What evidence excludes competing lineages, dead-cell artefacts and cell aggregates from this identification? boundary
Subset and biological context The cell's subset assignment, anatomical origin and relationship to differentiation boundaries.
A monocyte label does not establish a subset, tissue role or developmental destination.
Subset assignment
Qualified classification of monocyte phenotypic variation.
Human blood subset evidence
Represent classical, intermediate or nonclassical assignment only within an applicable classification framework.
- For a human blood monocyte, where do its CD14 and CD16 measurements fall relative to the documented subset gates? measurement
- Does the species, compartment or experimental condition make this subset terminology inapplicable or the assignment ambiguous? boundary
Compartment and transition
Source location and evidence relevant to persistence or change of monocyte identity.
Origin and differentiation boundary
Separate known specimen origin from inferred trafficking or differentiation history.
- From which species and anatomical compartment was the cell obtained, and what migration or culture history is actually documented? provenance
- What evidence supports retaining monocyte identity or transferring the cell to a macrophage or dendritic-cell model? boundary
Viability and functional state The monocyte's observed integrity, response state and experimentally demonstrated functions.
An agent needs measured capabilities and limitations to judge cell state without equating marker expression with function.
Integrity and response
Viability and condition-specific evidence of a response to stimulation or stress.
Viable response state
Keep viability and individual response readouts separate rather than collapsing them into one activation category.
- What viability or cell-death observations were made, by which assay and at what time relative to the functional readout? measurement
- Which marker, transcriptional or secretion changes were measured against which baseline after what exposure? measurement
Demonstrated functions
Direct evidence of monocyte activities under specified experimental conditions.
Function and inference limits
Record demonstrated uptake, migration or mediator production with controls and the correct unit of observation.
- Which function was directly measured, under what conditions, and does the result describe this cell or an assayed population? measurement
- What controls prevent interpreting particle binding as uptake, uptake as killing, or marker expression as demonstrated functional activity? boundary
Handling and permitted interpretation How specimen preparation affects the monocyte and which next actions remain suitable for the intended observation.
Collection and manipulation can alter monocyte recovery, phenotype and responses, so action choices require processing context.
Preanalytical history
Events between collection and observation that could change or select the measured monocytes.
Processing effects
Retain collection, isolation and storage history and identify evidence of resulting bias.
- Which anticoagulant, processing delays, isolation steps, temperatures, freeze-thaw events and culture conditions preceded observation? provenance
- What evidence indicates that processing changed monocyte viability, subset recovery, adherence or the markers used for classification? measurement
Next observation or manipulation
Selection of actions according to the unresolved question, current cell condition and assay compatibility.
Action and readout compatibility
Relate a proposed manipulation to the monocyte property it will test and the changes it may introduce.
- Which additional observation or manipulation would resolve the current monocyte identity or state uncertainty? action
- Would sorting, fixation, permeabilization, stimulation or culture compromise the intended readout or require reassessment of monocyte identity? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Kinds and varieties
Reported by the breadth pass; each item needs checking against its source before it becomes normative.
- classical CD14++ CD16- monocytes
- intermediate CD14++ CD16+ monocytes
- nonclassical CD14+ CD16++ monocytes
- inflammatory Ly6C-high monocytes (mouse)
- patrolling Ly6C-low monocytes (mouse)
- tissue-resident monocyte-derived macrophages
- monocyte-derived dendritic cells
- Which of these kinds and varieties hold for the sense of monocyte this model covers, and on what evidence? provenance
What the second pass must settle
- Which species and specimen compartments must the initial model support beyond its human blood reference scope?
- Which validated marker panels, exclusion criteria and subset gating references should govern each supported species and assay?
- What evidence threshold should trigger transfer from monocyte identity to a macrophage or dendritic-cell model in tissue and culture settings?
- Which processing conditions and time limits preserve the particular phenotypes and functions the intended applications need to measure?
- How should atypical or disease-associated monocyte phenotypes be represented when conventional identity or subset criteria do not resolve them?